CR9651A - Intermedios utiles en la sintesis de moduladores de alquilquinolina y alqilquinazolina cinasa y metodos relacionados de sintesis - Google Patents
Intermedios utiles en la sintesis de moduladores de alquilquinolina y alqilquinazolina cinasa y metodos relacionados de sintesisInfo
- Publication number
- CR9651A CR9651A CR9651A CR9651A CR9651A CR 9651 A CR9651 A CR 9651A CR 9651 A CR9651 A CR 9651A CR 9651 A CR9651 A CR 9651A CR 9651 A CR9651 A CR 9651A
- Authority
- CR
- Costa Rica
- Prior art keywords
- synthesis
- alquilquinolina
- alqilquinazolina
- cinasa
- modulators
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 2
- 238000003786 synthesis reaction Methods 0.000 title 2
- 239000000543 intermediate Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68938405P | 2005-06-10 | 2005-06-10 | |
| US73091905P | 2005-10-27 | 2005-10-27 | |
| US78955106P | 2006-04-05 | 2006-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR9651A true CR9651A (es) | 2008-09-09 |
Family
ID=37038264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR9651A CR9651A (es) | 2005-06-10 | 2008-01-09 | Intermedios utiles en la sintesis de moduladores de alquilquinolina y alqilquinazolina cinasa y metodos relacionados de sintesis |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7825244B2 (es) |
| EP (1) | EP1891040A1 (es) |
| JP (1) | JP2008545787A (es) |
| KR (1) | KR20080033234A (es) |
| AR (1) | AR054387A1 (es) |
| AU (1) | AU2006258056A1 (es) |
| BR (1) | BRPI0612543A2 (es) |
| CA (1) | CA2611219A1 (es) |
| CR (1) | CR9651A (es) |
| EA (1) | EA200800010A1 (es) |
| EC (1) | ECSP077993A (es) |
| GT (1) | GT200600250A (es) |
| IL (1) | IL187688A0 (es) |
| MX (1) | MX2007015739A (es) |
| NI (1) | NI200700312A (es) |
| NO (1) | NO20080160L (es) |
| PA (1) | PA8679201A1 (es) |
| TW (1) | TW200718694A (es) |
| UY (1) | UY29589A1 (es) |
| WO (1) | WO2006135646A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071768B2 (en) | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
| US7825244B2 (en) | 2005-06-10 | 2010-11-02 | Janssen Pharmaceutica Nv | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis |
| US8880138B2 (en) * | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
| CN105683167B (zh) * | 2013-10-16 | 2018-10-23 | 富士胶片株式会社 | 含氮杂环化合物的盐或其结晶、药品组合物及flt3抑制剂 |
| WO2016057931A1 (en) | 2014-10-10 | 2016-04-14 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3517005A (en) | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
| GB1460389A (en) | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
| JPS5976082A (ja) | 1982-10-23 | 1984-04-28 | Kyowa Hakko Kogyo Co Ltd | 新規なピペリジン誘導体 |
| GB8320958D0 (en) | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
| US5300515A (en) | 1991-01-31 | 1994-04-05 | Kyorin Pharmaceutical Co., Ltd. | Carbamic acid derivatives and method for preparing the same |
| EP0627940B1 (en) | 1992-03-05 | 2003-05-07 | Board of Regents, The University of Texas System | Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors |
| US5474765A (en) | 1992-03-23 | 1995-12-12 | Ut Sw Medical Ctr At Dallas | Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells |
| GB9510757D0 (en) | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| GB2295387A (en) | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
| CA2216943C (en) | 1995-04-19 | 2003-06-17 | Boston Scientific Limited | Drug release coated stent |
| WO1997028118A1 (en) | 1996-02-05 | 1997-08-07 | Hoechst Celanese Corporation | Process for preparing anthranilic acids |
| JP2001511764A (ja) | 1996-04-12 | 2001-08-14 | 住友製薬株式会社 | ピペリジニルピリミジン誘導体 |
| US5948786A (en) | 1996-04-12 | 1999-09-07 | Sumitomo Pharmaceuticals Company, Limited | Piperidinylpyrimidine derivatives |
| AU719392B2 (en) | 1996-10-01 | 2000-05-11 | Kyowa Hakko Kirin Co., Ltd. | Nitrogen-containing heterocyclic compounds |
| US5866562A (en) | 1996-10-25 | 1999-02-02 | Bayer Aktiengesellschaft | Ring-bridged bis-quinolines |
| JP2002508366A (ja) | 1997-12-12 | 2002-03-19 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | キノリンピペラジンおよびキノリンピペリジン誘導体、それらの製造方法、ならびに複合的５−ｈｔ１ａ、５−ｈｔ１ｂおよび５−ｈｔ１ｄ受容体アンタゴニストとしてのそれらの用途 |
| DE19756388A1 (de) | 1997-12-18 | 1999-06-24 | Hoechst Marion Roussel De Gmbh | Substituierte 2-Aryl-4-amino-chinazoline |
| GB9819382D0 (en) | 1998-09-04 | 1998-10-28 | Cerebrus Ltd | Chemical compounds I |
| ES2223705T3 (es) | 1999-04-28 | 2005-03-01 | Board Of Regents, The University Of Texas System | Composiciones y metodos para el tratamiento de cancer mediante inhibi cion selectiva del vegf. |
| SV2002000205A (es) | 1999-11-01 | 2002-06-07 | Lilly Co Eli | Compuestos farmaceuticos ref. x-01095 |
| US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
| WO2002016360A2 (en) | 2000-08-18 | 2002-02-28 | Cor Therapeutics, Inc. | Nitrogenous heterocyclic compounds |
| US6956039B2 (en) | 2000-08-18 | 2005-10-18 | Millennium Pharmaceuticals, Inc. | Nitrogenous heterocylic compounds |
| WO2002032861A2 (en) | 2000-10-17 | 2002-04-25 | Merck & Co., Inc. | Orally active salts with tyrosine kinase activity |
| US6566367B2 (en) | 2000-12-12 | 2003-05-20 | Pfizer Inc. | Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines |
| DE10109866A1 (de) | 2001-03-01 | 2002-09-05 | Abbott Gmbh & Co Kg | Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie |
| DE60227794D1 (de) | 2001-04-26 | 2008-09-04 | Eisai R&D Man Co Ltd | Stickstoffhaltige verbindung mit kondensiertem ring und pyrazolylgruppe als substituent und medizinische zusammensetzung davon |
| TWI238824B (en) | 2001-05-14 | 2005-09-01 | Novartis Ag | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives |
| WO2003024931A1 (en) | 2001-09-14 | 2003-03-27 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| US7101884B2 (en) | 2001-09-14 | 2006-09-05 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| TWI259081B (en) | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
| CN101703509A (zh) | 2001-10-30 | 2010-05-12 | 诺瓦提斯公司 | 作为flt3受体酪氨酸激酶活性抑制剂的星形孢菌素衍生物 |
| EP1458713B1 (en) | 2001-12-27 | 2005-08-24 | Theravance, Inc. | Indolinone derivatives useful as protein kinase inhibitors |
| DK1474420T3 (da) | 2002-02-01 | 2012-05-21 | Astrazeneca Ab | Quinazolinforbindelser |
| AR037647A1 (es) | 2002-05-29 | 2004-12-01 | Novartis Ag | Derivados de diarilurea utiles para el tratamiento de enfermedades dependientes de la cinasa de proteina |
| MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
| IL165871A0 (en) | 2002-06-27 | 2006-01-15 | Schering Ag | Substituted quinoline CCR5 receptor antagonists |
| GB0215676D0 (en) | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| EP1546117A2 (en) | 2002-08-14 | 2005-06-29 | Vertex Pharmaceuticals Incorporated | Protein kinase inhibitors and uses thereof |
| BR0313743A (pt) | 2002-08-23 | 2005-07-05 | Chiron Corp | Benzimidazol quinolinonas e usos destas |
| US20080207617A1 (en) | 2002-10-29 | 2008-08-28 | Kirin Beer Kabushiki Kaisha | Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphrylation of Flt3 and Medicinal Compositions Containing the Same |
| MXPA05004754A (es) | 2002-11-13 | 2005-08-02 | Chiron Corp | Metodos para tratar cancer y metodos relacionados. |
| TWI335913B (en) | 2002-11-15 | 2011-01-11 | Vertex Pharma | Diaminotriazoles useful as inhibitors of protein kinases |
| WO2004058749A1 (en) | 2002-12-18 | 2004-07-15 | Vertex Pharmaceuticals Incorporated | Benzisoxazole derivatives useful as inhibitors of protein kinases |
| AU2003299791A1 (en) | 2002-12-20 | 2004-07-22 | Bayer Pharmaceuticals Corporation | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
| TW200508224A (en) | 2003-02-12 | 2005-03-01 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
| US7163937B2 (en) | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| ES2344007T3 (es) | 2003-10-14 | 2010-08-16 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Inhibidores proteina quinasa. |
| EP1684694A2 (en) | 2003-11-21 | 2006-08-02 | Array Biopharma, Inc. | Akt protein kinase inhibitors |
| US8071768B2 (en) | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
| US7825244B2 (en) | 2005-06-10 | 2010-11-02 | Janssen Pharmaceutica Nv | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis |
-
2006
- 2006-06-06 US US11/422,352 patent/US7825244B2/en active Active
- 2006-06-07 MX MX2007015739A patent/MX2007015739A/es unknown
- 2006-06-07 EP EP06760725A patent/EP1891040A1/en not_active Withdrawn
- 2006-06-07 KR KR1020087000200A patent/KR20080033234A/ko not_active Withdrawn
- 2006-06-07 AU AU2006258056A patent/AU2006258056A1/en not_active Abandoned
- 2006-06-07 JP JP2008515888A patent/JP2008545787A/ja not_active Withdrawn
- 2006-06-07 WO PCT/US2006/022171 patent/WO2006135646A1/en not_active Ceased
- 2006-06-07 BR BRPI0612543-3A patent/BRPI0612543A2/pt not_active IP Right Cessation
- 2006-06-07 CA CA002611219A patent/CA2611219A1/en not_active Abandoned
- 2006-06-07 EA EA200800010A patent/EA200800010A1/ru unknown
- 2006-06-08 UY UY29589A patent/UY29589A1/es unknown
- 2006-06-08 GT GT200600250A patent/GT200600250A/es unknown
- 2006-06-08 PA PA20068679201A patent/PA8679201A1/es unknown
- 2006-06-09 AR ARP060102423A patent/AR054387A1/es not_active Application Discontinuation
- 2006-06-09 TW TW095120478A patent/TW200718694A/zh unknown
-
2007
- 2007-11-27 IL IL187688A patent/IL187688A0/en unknown
- 2007-11-29 NI NI200700312A patent/NI200700312A/es unknown
- 2007-12-10 EC EC2007007993A patent/ECSP077993A/es unknown
-
2008
- 2008-01-09 CR CR9651A patent/CR9651A/es not_active Application Discontinuation
- 2008-01-09 NO NO20080160A patent/NO20080160L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL187688A0 (en) | 2008-08-07 |
| JP2008545787A (ja) | 2008-12-18 |
| NI200700312A (es) | 2009-02-19 |
| AU2006258056A1 (en) | 2006-12-21 |
| EA200800010A1 (ru) | 2008-06-30 |
| BRPI0612543A2 (pt) | 2010-11-23 |
| NO20080160L (no) | 2008-01-09 |
| PA8679201A1 (es) | 2007-01-17 |
| MX2007015739A (es) | 2008-04-29 |
| ECSP077993A (es) | 2008-01-23 |
| GT200600250A (es) | 2007-03-14 |
| CA2611219A1 (en) | 2006-12-21 |
| US7825244B2 (en) | 2010-11-02 |
| TW200718694A (en) | 2007-05-16 |
| WO2006135646A1 (en) | 2006-12-21 |
| US20070021436A1 (en) | 2007-01-25 |
| UY29589A1 (es) | 2006-10-02 |
| KR20080033234A (ko) | 2008-04-16 |
| AR054387A1 (es) | 2007-06-20 |
| EP1891040A1 (en) | 2008-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1920065T (pt) | Anticorpos anti-alfavbeta6 e suas utilizações | |
| DK1934179T3 (da) | Fremgangsmåder og mellemprodukter | |
| EP1857091A4 (en) | COSMETIC | |
| CY2013046I2 (el) | Καινοτομος χρηση των αντισωματων αντι il-1bhta | |
| EP1883519A4 (en) | HYDROGEL CONSTRUCTS MANUFACTURED BY STEREOLITHOGRAPHY | |
| HRP20220755T3 (hr) | Anti-gm-csf antitijela i njihova uporaba | |
| EP2023656A4 (en) | ACOUSTIC EXTRACTION DEVICE AND LOUDSPEAKER THEREFOR | |
| HUE044756T2 (hu) | HER-3 elleni antitestek és alkalmazásuk | |
| IL187303A0 (en) | Methods of prepering 3 - cyano - quinolines and intermediates made thereby | |
| BRPI0909954A2 (pt) | "diazacarbazóis e métodos de uso" | |
| DE602006004463D1 (de) | Kristallform von asenapinmaleat | |
| DE602005022364D1 (de) | Selbstbräunendes kosmetikum | |
| DE602006018166D1 (de) | Polyrotaxanhaltige lösung und verwendung davon | |
| DE602006003063D1 (de) | Tripeptid- und tetrapeptidsulfone | |
| CR9651A (es) | Intermedios utiles en la sintesis de moduladores de alquilquinolina y alqilquinazolina cinasa y metodos relacionados de sintesis | |
| EP1915162A4 (en) | Modulators | |
| DK1736159T3 (da) | Hudplejemiddel | |
| EP1910272A4 (en) | Renin Inhibitors | |
| EP1722013A4 (en) | GALVANIZATION IN THE PRESENCE OF CO2 | |
| FR2877833B1 (fr) | Correcteur de lordoses | |
| EP1942012A4 (en) | COVER FIXING DEVICE | |
| ZA200800276B (en) | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis | |
| ES1061722Y (es) | Pavimento desmontable | |
| DE602005002738D1 (de) | Syntheseverfahren und benzoxathiepinzwischenprodukte | |
| DE102004062128B8 (de) | Elektroakustischer Wandler und dessen Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |